Head and neck cancer consensus recommendations

Heterogeneity in diagnostic criteria for extranodal extensions results in inconsistencies in clinical decision making. Moreover, there is an urgent need for standardisation of endpoints in clinical trials for head and neck cancer. In this four-part Series by The Lancet Oncology, the Head and Neck Cancer International Group—a consortium of 21 national head and neck oncology research groups—provides consensus recommendations for clear definitions of extranodal extensions and clinical-trial endpoints to inform and standardise clinical practice globally. https://www.thelancet.com/series/head-and-neck-cancer-consensus-recommendations?dgcid=hubspot_email_infocusalerts-oncology_feature_lanoncheadneckcancer24&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz--39y8Juo1h7k3zHCNmCAjen0kdGJsVP3PK8KcxJl2XmxKcVsbAnYUScL7VYQtoeRpzCEp1MijvzPTZY0SH1tfQEoDaCA&_hsmi=324659725&utm_content=322872993&utm_source=hs_email